Wie hoch ist der Preis für Kestra Medical Technologies, Ltd. (KMTS)

Preis für Kestra Medical Technologies, Ltd. (KMTS) ist $26.16

Wie hoch ist die Marktkapitalisierung für Kestra Medical Technologies, Ltd. (KMTS)

Marktkapitalisierung für Kestra Medical Technologies, Ltd. (KMTS) ist $1.53B

Kestra Medical Technologies, Ltd. (KMTS) Operative Marge

Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.

Jahr	Operative Marge	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Operative Marge

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Operative Marge	Differenz der operativen Marge	Land
Intuitive Surgical, Inc. ISRG.US	31.28%	-	US
EssilorLuxottica S.A. EL.PA	12.36%	-	FR
HOYA Corporation 7741.T	0.00%	-	JP
Becton, Dickinson and Company BDX.US	9.83%	-	US
Alcon Inc. ALC.SW	0.00%	-	CH

Unternehmen

Operative Marge

Differenz der operativen Marge

Land